Trial Outcomes & Findings for Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer (NCT NCT03089125)

NCT ID: NCT03089125

Last Updated: 2025-02-27

Results Overview

Compare the difference between study groups in the Modified Medical Research Council Dyspnea Scale severity score at 8 weeks. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

247 participants

Primary outcome timeframe

8 weeks

Results posted on

2025-02-27

Participant Flow

Participant milestones

Participant milestones
Measure
Usual Care
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Overall Study
STARTED
121
126
Overall Study
COMPLETED
99
94
Overall Study
NOT COMPLETED
22
32

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Total
n=247 Participants
Total of all reporting groups
Age, Continuous
65.44 years
STANDARD_DEVIATION 10.08 • n=121 Participants
66.83 years
STANDARD_DEVIATION 11.47 • n=126 Participants
66.15 years
STANDARD_DEVIATION 10.81 • n=247 Participants
Sex: Female, Male
Female
70 Participants
n=121 Participants
68 Participants
n=126 Participants
138 Participants
n=247 Participants
Sex: Female, Male
Male
51 Participants
n=121 Participants
58 Participants
n=126 Participants
109 Participants
n=247 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=121 Participants
3 Participants
n=126 Participants
4 Participants
n=247 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
118 Participants
n=121 Participants
117 Participants
n=126 Participants
235 Participants
n=247 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=121 Participants
6 Participants
n=126 Participants
8 Participants
n=247 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=121 Participants
0 Participants
n=126 Participants
0 Participants
n=247 Participants
Race (NIH/OMB)
Asian
2 Participants
n=121 Participants
6 Participants
n=126 Participants
8 Participants
n=247 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=121 Participants
0 Participants
n=126 Participants
0 Participants
n=247 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=121 Participants
5 Participants
n=126 Participants
7 Participants
n=247 Participants
Race (NIH/OMB)
White
113 Participants
n=121 Participants
110 Participants
n=126 Participants
223 Participants
n=247 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=121 Participants
4 Participants
n=126 Participants
6 Participants
n=247 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=121 Participants
1 Participants
n=126 Participants
3 Participants
n=247 Participants
Region of Enrollment
United States
121 participants
n=121 Participants
126 participants
n=126 Participants
247 participants
n=247 Participants
Modified Medical Research Council Dyspnea Scale (mMRCDS)
2.60 units on a scale
STANDARD_DEVIATION 0.75 • n=121 Participants
2.59 units on a scale
STANDARD_DEVIATION 0.72 • n=126 Participants
2.60 units on a scale
STANDARD_DEVIATION 0.73 • n=247 Participants
Cancer Dyspnoea Scale (CDS)
12.61 units on a scale
STANDARD_DEVIATION 7.51 • n=121 Participants
11.13 units on a scale
STANDARD_DEVIATION 6.51 • n=126 Participants
11.85 units on a scale
STANDARD_DEVIATION 7.05 • n=247 Participants
Functional Assessment of Cancer Therapy - Lung (FACT-L)
87.23 units on a scale
STANDARD_DEVIATION 16.36 • n=121 Participants
90.19 units on a scale
STANDARD_DEVIATION 18.59 • n=126 Participants
88.74 units on a scale
STANDARD_DEVIATION 17.56 • n=247 Participants
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
6.68 units on a scale
STANDARD_DEVIATION 3.76 • n=121 Participants
5.37 units on a scale
STANDARD_DEVIATION 3.80 • n=126 Participants
6.01 units on a scale
STANDARD_DEVIATION 3.83 • n=247 Participants
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
6.40 units on a scale
STANDARD_DEVIATION 3.16 • n=121 Participants
5.73 units on a scale
STANDARD_DEVIATION 3.72 • n=126 Participants
6.06 units on a scale
STANDARD_DEVIATION 3.47 • n=247 Participants
Godin-Shephard Leisure Time Physical Activity Questionnaire
11.19 units on a scale
STANDARD_DEVIATION 18.20 • n=115 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
12.29 units on a scale
STANDARD_DEVIATION 16.91 • n=117 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
11.75 units on a scale
STANDARD_DEVIATION 17.53 • n=232 Participants • 6 participants in the Usual Care Group and 9 participants in the Dyspnea Intervention Group did not complete the baseline Godin-Shephard Leisure Time Physical Activity Questionnaire.
Actigraphy
50.48 Percent time spent immobile while awake
STANDARD_DEVIATION 13.62 • n=84 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.
47.61 Percent time spent immobile while awake
STANDARD_DEVIATION 11.19 • n=89 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.
49.00 Percent time spent immobile while awake
STANDARD_DEVIATION 12.48 • n=173 Participants • 37 participants in the Usual Care Group and 37 participants in the Dyspnea Intervention Group did not have three consecutive days of actigraphy data at baseline.

PRIMARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring care.

Compare the difference between study groups in the Modified Medical Research Council Dyspnea Scale severity score at 8 weeks. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.

Outcome measures

Outcome measures
Measure
Usual Care
n=98 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Modified Medical Research Council Dyspnea Scale (mMRCDS)
1.88 units on a scale
Interval 1.69 to 2.07
1.55 units on a scale
Interval 1.35 to 1.75

PRIMARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring care.

Compare the difference between study groups in the Cancer Dyspnoea Scale scores at 8 weeks. The Cancer Dyspnoea Scale scores range from 0 (minimum) to 48 (maximum), with higher scores indicating worse dyspnea.

Outcome measures

Outcome measures
Measure
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Cancer Dyspnoea Scale (CDS)
10.01 units on a scale
Interval 8.87 to 11.15
9.47 units on a scale
Interval 8.28 to 10.65

SECONDARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.

Compare the difference between study groups in the Functional Assessment of Cancer Therapy - Lung Scale scores at 8 weeks. The Functional Assessment of Cancer Therapy - Lung Scale scores range from 0 (minimum) to 136 (maximum), with higher scores indicating better quality of life.

Outcome measures

Outcome measures
Measure
Usual Care
n=97 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=91 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Functional Assessment of Cancer Therapy - Lung (FACT-L)
91.40 units on a scale
Interval 88.91 to 93.89
93.00 units on a scale
Interval 90.43 to 95.57

SECONDARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.

Compare the difference between study groups in the Hospital Anxiety and Depression Scale - Anxiety Subscale scores at 8 weeks. The Hospital Anxiety and Depression Scale - Anxiety Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse anxiety symptoms.

Outcome measures

Outcome measures
Measure
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
5.85 units on a scale
Interval 5.27 to 6.42
5.84 units on a scale
Interval 5.25 to 6.43

SECONDARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.

Compare the difference between study groups in the Hospital Anxiety and Depression Scale - Depression Subscale scores at 8 weeks. The Hospital Anxiety and Depression Scale - Depression Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse depression symptoms.

Outcome measures

Outcome measures
Measure
Usual Care
n=99 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=92 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
6.09 units on a scale
Interval 5.5 to 6.67
5.59 units on a scale
Interval 4.99 to 6.2

SECONDARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.

Compare the difference between study groups in the Godin-Shephard Leisure Time Physical Activity Questionnaire scores at 8 weeks. The Godin-Shephard Leisure Time Physical Activity Questionnaire is a 4-item measure that assesses the frequency and extent of physical activity during free time over the course of one week, with scores ranging from 0 (minimum; insufficiently active) to 24 or greater (maximum; active), with higher scores indicating greater physical activity.

Outcome measures

Outcome measures
Measure
Usual Care
n=90 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=74 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Activity Level (Self-report: Godin-Shephard Leisure Time Physical Activity Questionnaire)
12.73 units on a scale
Interval 8.43 to 17.03
11.24 units on a scale
Interval 6.5 to 15.98

SECONDARY outcome

Timeframe: 8 weeks

Population: Reasons for missing data include participants being unable to complete study measures due to worsening illness or death, withdrawing from the study, declining to complete the measures, or being lost to follow-up or transferring their care to another institution.

Compare the difference between study groups in the percentage of time spent immobile but awake over a consecutive three day period per actigraphy at 8 weeks. Scores range from 0% to 100%, with higher scores indicating a greater percentage of time spent immobile while awake over a consecutive three day period.

Outcome measures

Outcome measures
Measure
Usual Care
n=55 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=47 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Activity Level (Objective Measure: Actigraphy)
45.80 percent time spent immobile while awake
Interval 43.06 to 48.53
47.42 percent time spent immobile while awake
Interval 44.46 to 50.38

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Modified Medical Research Council Dyspnea Scale outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Modified Medical Research Council Dyspnea Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Modified Medical Research Council Dyspnea Scale scores range from 0 (minimum) to 4 (maximum), with higher scores indicating more severe dyspnea.

Outcome measures

Outcome measures
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Modified Medical Research Council Dyspnea Scale (mMRCDS)
-0.89 mean change in scores on a scale
Interval -1.16 to -0.61
-0.95 mean change in scores on a scale
Interval -1.24 to -0.66

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Cancer Dyspnoea Scale outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Cancer Dyspnoea Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Cancer Dyspnoea Scale scores range from 0 (minimum) to 48 (maximum), with higher scores indicating worse dyspnea.

Outcome measures

Outcome measures
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Cancer Dyspnoea Scale (CDS)
-2.63 mean change in scores on a scale
Interval -4.13 to -1.13
-2.26 mean change in scores on a scale
Interval -3.84 to -0.67

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Functional Assessment of Cancer Therapy - Lung Scale outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Functional Assessment of Cancer Therapy - Lung Scale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Functional Assessment of Cancer Therapy - Lung Scale scores range from 0 (minimum) to 136 (maximum), with higher scores indicating better quality of life.

Outcome measures

Outcome measures
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Functional Assessment of Cancer Therapy - Lung (FACT-L)
4.86 mean change in scores on a scale
Interval 1.57 to 8.14
2.91 mean change in scores on a scale
Interval -0.6 to 6.41

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Hospital Anxiety and Depression Scale - Anxiety Subscale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Hospital Anxiety and Depression Scale - Anxiety Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse anxiety symptoms.

Outcome measures

Outcome measures
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale
-1.00 mean change in scores on a scale
Interval -1.73 to -0.28
-0.28 mean change in scores on a scale
Interval -1.04 to 0.49

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Hospital Anxiety and Depression Scale - Depression Subscale outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Hospital Anxiety and Depression Scale - Depression Subscale over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Hospital Anxiety and Depression Scale - Depression Subscale scores range from 0 (minimum) to 21 (maximum), with higher scores indicating worse depression symptoms.

Outcome measures

Outcome measures
Measure
Usual Care
n=121 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=126 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Hospital Anxiety and Depression Scale (HADS) - Depression Subscale
-0.18 mean change in scores on a scale
Interval -0.89 to 0.53
-0.10 mean change in scores on a scale
Interval -0.85 to 0.66

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Population: The analysis sample includes the total number of participants by group who completed at least one Godin-Shephard Leisure Time Physical Activity Questionnaire outcome measure from baseline to 24 weeks.

Compare the difference between study groups in the estimated slopes of the scores on the Godin-Shephard Leisure Time Physical Activity Questionnaire over all four assessment timepoints of 8-week intervals (i.e., baseline, 8 weeks, 16 weeks, and 24 weeks) using linear mixed effects models. The Godin-Shephard Leisure Time Physical Activity Questionnaire is a 4-item measure that assesses the frequency and extent of physical activity during free time over the course of one week, with scores ranging from 0 (minimum; insufficiently active) to 24 or greater (maximum; active), with higher scores indicating greater physical activity.

Outcome measures

Outcome measures
Measure
Usual Care
n=119 Participants
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians. Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Dyspnea Intervention
n=121 Participants
Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Dyspnea Intervention: Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness Usual Care: Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians
Activity Level (Self-report: Godin-Shephard Leisure Time Physical Activity Questionnaire)
0.54 mean change in scores on a scale
Interval -5.3 to 6.38
1.28 mean change in scores on a scale
Interval -5.09 to 7.65

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Examine the degree to which intervention effects on patient reported outcomes are mediated by improved mastery in managing breathlessness (as measured by the Chronic Respiratory Disease Questionnaire)

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Examine whether differences in reported dyspnea are moderated by patient demographic and clinical factors

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 weeks

Examine differences between study groups in rates of emergency department and hospitalizations

Outcome measures

Outcome data not reported

Adverse Events

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 23 deaths

Dyspnea Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 17 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Joseph A. Greer, Ph.D.

Massachusetts General Hospital

Phone: 617-643-2143

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place